Tweets by scisetglobal

Clinical Trials and Case Reports

Clinical Trials and Case Reports, a peer-reviewed open-access journal published by Sciset Publishers, embraces the global nature of epidemiology by fostering open debate across diverse fields, applications, and geographical regions. Our mission is to serve as a platform for the dissemination of high-quality Clinical Trials and Case Reports research and methodological advancements.

Primarily focusing on statistical genetics, our journal is dedicated to the development and application of statistical, bioinformatics, and computational models for analyzing genetic data. We present evidence from hypothesis-testing studies, ranging from pilot projects to large retrospective analyses, aiming to contribute to the advancement of the field.

Clinical Trials and Case Reports invites original research articles, review articles, case reports, mini-reviews, rapid communications, opinions, editorials, video articles, and PowerPoint presentations related to Clinical Trials and Case Reports, thereby facilitating the exchange of the latest research findings and applications among researchers worldwide.

Ideal Topics: Surgical Case Reports, Clinical Gastro, Clinical hepatology, Injuries, Zika virus, Huma Anatomy and Physiology, Cardiology, Pain Medicine, Arthritis, Rehabilitation, laparoscopic cholecystectomy, immunocompromised diseases, Endocrine Manifestations, Congenital bronchobiliary fistula, thoracolumbar fracture panhypopituitarism, Thalassemia, multinodular goiter, Obesity, Pancreaticodoudenectomy, thyroid, pulmonary embolism, osteosarcoma, neuroendocrine tumor, Dengue Virus, sleep apnea, Coronary Artery Disease, neck fracture, cardiomyopathy, migration, lung transplant, Pembrolizumab, Eosinophilic esophagitis, lumbar drainage, Boerhaave's syndrome.

Our journal covers a broad spectrum of topics including:

• Academic Clinical Trials
• Bioequivalence
• Biopharmaceutical
• Biopharmacology
• Biotechnology
• Clinical Examination
• Clinical Medicine
• Clinically Significant Images
• Diagnostic Techniques
• Drug Development
• Drug Effects or Interactions
• Emerging Diseases
• Epidemiological Methods
• New Infections
• Outbreak in Local Community
• Pathogenesis of A Disease
• Pharmacodynamics
• Pharmacokinetics
• Pharmacology
• Pharmacometrics
• Pharmacovigilance
• Presentations of A Disease
• Rare Diseases
• Treating A Patient
• Unexpected Diseases or Symptoms
• Variations in Disease Processes
• Case Reports

No Profit-Oriented Goal Setting, No Hidden Clues

We believe a manuscript is the ultimate form of contribution of a researcher for the betterment of the global community. Impactful researches should be available to global readers with no hindrance. We never claim Publication Fees beyond the limit of the researchers.

Editorial Board

The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.

Peer Review

The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.

Managing Editor’s Role

Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.

Rapid and Fast Publication

All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.